Eicosanoids

Peter Curtis-Prior is the editor of The Eicosanoids, published by Wiley.

"Investigators with either or a basic or clinical interest in the metabolism of essential fatty acids and eicosanoid production have all such information at hand in this excellent compendium." (New England Journal of Medicine, March 17, 2005) "…it serves to effectively communicate the most current information on eicosanoids in an understandable manner.” (E-STREAMS, September 2004)

• List of Contributors. Preface.Preface from Prostaglandins.Acknowledgements.Foreword.Section One: Biosynthesis and Metabolism1. Perspectives on the Biosynthesis and Metabolism of Eicosanoids (Robert C. Murphy, Rebecca C. Bowers, Jennifer Dickinson and Karin Zemski-Berry).2. Control of Eicosanoid Production by Cellular and Secreted Phospholipase A2 (Marise Andreani, Jean-Luc Olivier and Gilbert Béréziat).3. Mechanisms of PGH synthase-1 (COX-1) activity and role of radical states (Carol Deby and Ginette Deby-Dupont ).4. Regulation and Function of Prostaglandin Synthase 2/Cyclooxygenase II (Harvey R. Herschman).5. Mammalian Lipoxygenases  (Shozo Yamamoto, Hiroshi Suzuki, Natsuo Ueda, Yoshitaka Takahashi and Tanihiro Yoshimoto).6. Biosynthesis and Biological Effects of 5-oxo-ETE and other Oxoeicosatetraenoic Acids (William S. Powell).7. Synthetic Eicosanoids (Norrie. H. Wilson).Section Two: Analytic al Methods8. Perspectives of Analytical Methods for Eicosanoids  (Jay Y. Westcott and Angelo Sala).9. Enzyme Immunoassays of Metabolites and Enzymes Using Acetylcholinesterase as label (Christophe Créminon and Jacques Maclouf).10.Bioassay of Eicosanoids (Robert L. Jones).11. Gas Chromatography and Mass Spectometry in Eicosanoid Analysis (Michinao Mizugaki, Takanori Hishinuma, Naoto Suzuki).12. Time-resolved Fluoroimmunoassay in Eicosanoid Analysis (Werner Schlegel and Harald John).Section Three: Biochemical and Molecular Pharmacology13. Perspectives and Clinical Significance of the Biochemical and Molecular Pharmacology of Eicosanoids  (Subhash P. Khanapure and L. Gordon Letts).14. Eicosanoid Antagonists (Kiyoshi Yasui and Akinori Arimura).15. Biosynthesis and Degredation of Anandamide, an Endogenous Ligand of Cannabinoid Receptors (Natsuo Ueda and Dale G. Deutsch).16. Inhibitors of Eicosanoids (K. D. Rainsford).17. Biology and Chemistry of Products of the Isoprostane Pathway (L. Jackson Roberts, II, and Jason D. Morrow).18. Insight into Prostanoid Functions; lessons from receptor-knockout mice (Yukihiko Sugimoto, Shuh Narumiya and Atsushi Ichikawa).Section Four: Immunology, Endocrinology and Metabolic Regulation19. Perspectives and Clinical Significance of Eicosanoids in Immunology, Endocrinology and Metabolic Regulation (Milan R. Henzl).20. Prostaglandins and the Immune Response (Diana C. Fleming and Rodney W. Kelly).21. Leukotrienes in Aspirin-intolerant Asthma (Anthony P. Sampson and Stephen T. Holgate).22. Essential Fatty Acids (Yoeju Min and Michael A. Crawford).23. Endothelial Secretory Function and Atherothrombosis (Stefan Chlopicki and Richard J. Gryglewski).24. Molecular Regulation of Pancreatic Islet Prostaglandin Sythesis and Its Relevance to Diabetes Mellitus (R. Paul Robertson).25. Prostaglandins, Leukotrienes and Bone (Carol C. Pilbeam and Lawrence G. Raisz).26. Aging and Prostaglandins (A. Hornych).Section Five: Inflammation27. Perspectives and Clinical Significance of Eicosanoids in Pain and Inflammation (Burkhard Hinz and Kay Brune).28. Anti-Inflammatory Steroids (Françoise Russo-Marie).29. Eicosanoids and Algesia in Inflammation (Lynne Murray, Henry Sarau and Kristen E. Belmonte).30. Cyclooxygenase-2 in Cancer (Ovidiu C. Trifan and Jaime L. Masferrer).31. Cytokines and Eicosanoids in Arthritis (K. D. Rainsford).Section Six: Circulatory Systems32. Prespectives and Clinical Significance of Eicosanoids in the Circulatory System (James B. Lee).33. Aspirin and Activated Platelets (Artur-Aron Weber).34. Generation of Vasoactive Prostanoids by the Cyclooxygenase-2 Pathway in the Cardiovascular System of the Rat (P. J. Kadowitz, S. R. Baber, M. M. Mazim, M. Keebler, H. C. Champion, T. J. Bivalacqua, D. B. McNamara and A. L. Hyman).35. Eicosanoid Generation and Effects in Cardiac Muscle and Coronary Vessels (Karsten Schrör).Section Seven: Digestive System36. Perspective and Clinical Significance of Eicosanoids in the Digestive System (Chi Hin Cho, Joshua Ka Shun Ko and Marcel Wing Leung Koo).37. Eicosanoids and Liver Regeneration (David A. Rudnick and Louis J. Muglia).38. Eicosanoids and the Intestine (Klaus Bukhave and Jørgen Rask-Madsen).39. Eicosanoids and Stomach Physiology (Brigitta M. Peskar).Section Eight: Nervous System40. Perspectives and Clinical Significance of Arachidonic Acid Release, Action and Metabolism In the Nervous System (Christopher D. Breder).41. Eicosanoid Pathways in the Aging of the Central Nervous System (Hari Manev and Tolga Uz).42. Arachidonate Metabolites in the Neurophysiological System: The Fever Pathway (Ji Zhang and Serge Rivest).43. Prostanoids in Pain (Tony L. Yaksh, Patrick W. Mantyh and Camilla I. Svensson).44. Eicosanoids: Roles in the Pathophysiology of Cerebral Ischemia (Robert W. Hickey and Steven H. Graham).45. NSAIDs in the Treatment of Alzheimer’s Disease (Paul S. Aisen).46. Prostaglandins and Eicosanoids (A.I.M. Glen and B.M. Ross).47. Essential Fatty Acids: Eicosanoid Precursors in the Treatment of Huntington’s Disease (Krishna Vaddadi).Section Nine: Conclusions and Correlations48. Perspectives and Clinical Significance of Eicosanoids in Obstetrics and Gynaecologic Practice (I. Z. MacKenzie).49. Prostaglandins and Male Reproductive Physiology (Rodney W. Kelly).50. Prostaglandin F2: The Luteolytic Hormone (John A. McCracken).51. Prostaglandins in Implantation (Norman L. Poyser).52. Parturition and the Clinical Interruption of Pregnancy (S. Cowan and A.A. Calder).53. Foetal and Neonatal Ductus Arteriosus (Kazuo Momma).Section Ten: Conclusions and Correlations54. Biochemical Interactions of Platelet-Activating Factor with Eicosanoids (Joseph T. O’Flaherty and Robert L. Wykle).55. Eicosanoid Precursors as Pharmaceuticals (David F. Horrobin).56. Pharmaceutical Exploitation: cyclooxygenase and lipoxygenase inhibitors (Paola Patrignani and Maria G. Sciulli).57. Pharmaceutical Exploitation: Eicosanoids and their Analogs (David F. Woodward and June Chen).Epilogue.Index.